Tavaborole


Tavaborole is a topical antifungal medication used for the treatment of onychomycosis, a fungal infection of the nails. It is marketed under the brand name Kerydin. Tavaborole is notable for its ability to penetrate the nail plate and reach the site of infection, which is essential for effective treatment.
Mechanism of Action[edit]
Tavaborole works by inhibiting an essential fungal enzyme called leucyl-tRNA synthetase. This enzyme is crucial for the synthesis of fungal proteins. By inhibiting this enzyme, tavaborole disrupts protein synthesis, leading to fungal cell death.
Indications[edit]
Tavaborole is specifically indicated for the treatment of onychomycosis of the toenails caused by Trichophyton rubrum or Trichophyton mentagrophytes. It is applied topically to the affected nail(s) once daily for a period of 48 weeks.
Application[edit]
The medication is available as a 5% solution. Patients are advised to apply tavaborole to the entire surface of the affected toenail, including the undersurface of the nail tip, using the provided dropper. It is important to follow the prescribed duration of treatment to achieve optimal results.
Side Effects[edit]
Common side effects of tavaborole include application site exfoliation, erythema, and dermatitis. These side effects are generally mild and transient. However, patients should consult their healthcare provider if they experience severe or persistent side effects.
Clinical Studies[edit]
Clinical trials have demonstrated the efficacy of tavaborole in treating onychomycosis. In these studies, a significant percentage of patients achieved a complete or almost complete cure of their fungal infection after 48 weeks of treatment.
Comparison with Other Treatments[edit]
Tavaborole is one of several topical treatments available for onychomycosis. Other treatments include ciclopirox and efinaconazole. Compared to these treatments, tavaborole has shown a favorable safety profile and good efficacy in clinical trials.
Conclusion[edit]
Tavaborole is a valuable option for patients suffering from onychomycosis, offering a targeted approach to treating fungal infections of the toenails. Its unique mechanism of action and ability to penetrate the nail plate make it an effective treatment choice.
See Also[edit]
References[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian